BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23034180)

  • 1. NMI mediates transcription-independent ARF regulation in response to cellular stresses.
    Li Z; Hou J; Sun L; Wen T; Wang L; Zhao X; Xie Q; Zhang SQ
    Mol Biol Cell; 2012 Dec; 23(23):4635-46. PubMed ID: 23034180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2.
    Wang J; He X; Luo Y; Yarbrough WG
    Biochem J; 2006 Jan; 393(Pt 2):489-501. PubMed ID: 16173922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
    Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
    Nat Commun; 2013; 4():1551. PubMed ID: 23462994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
    Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
    Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
    Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function.
    Kowalczyk D; Nakasone MA; Smith BO; Huang DT
    Life Sci Alliance; 2022 Aug; 5(12):. PubMed ID: 35944929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide induced NMI promotes cell apoptosis by activating the ARF-p53 signaling pathway in lung carcinoma.
    Song D; Zhao J; Su C; Jiang Y; Hou J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):368-374. PubMed ID: 29030066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
    Chen D; Yoon JB; Gu W
    Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL; Gu W
    Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
    Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
    Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
    Fu X; Yucer N; Liu S; Li M; Yi P; Mu JJ; Yang T; Chu J; Jung SY; O'Malley BW; Gu W; Qin J; Wang Y
    Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4579-84. PubMed ID: 20173098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 ubiquitination: Mdm2 and beyond.
    Brooks CL; Gu W
    Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoactivation of the MDM2 E3 ligase by intramolecular interaction.
    Cheng Q; Song T; Chen L; Chen J
    Mol Cell Biol; 2014 Aug; 34(15):2800-10. PubMed ID: 24842904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.
    Vivo M; Ranieri M; Sansone F; Santoriello C; Calogero RA; Calabrò V; Pollice A; La Mantia G
    PLoS One; 2013; 8(1):e53631. PubMed ID: 23308265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.
    Tompkins VS; Hagen J; Frazier AA; Lushnikova T; Fitzgerald MP; di Tommaso A; Ladeveze V; Domann FE; Eischen CM; Quelle DE
    J Biol Chem; 2007 Jan; 282(2):1322-33. PubMed ID: 17110379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
    Kamrul HM; Wadhwa R; Kaul SC
    Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM2-mediated degradation of p14ARF: a novel mechanism to control ARF levels in cancer cells.
    Vivo M; Matarese M; Sepe M; Di Martino R; Festa L; Calabrò V; La Mantia G; Pollice A
    PLoS One; 2015; 10(2):e0117252. PubMed ID: 25723571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
    Chen D; Shan J; Zhu WG; Qin J; Gu W
    Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.